191 related articles for article (PubMed ID: 15325197)
21. The role of alemtuzumab in the management of T-cell malignancies.
Dearden C
Semin Oncol; 2006 Apr; 33(2 Suppl 5):S44-52. PubMed ID: 16720203
[TBL] [Abstract][Full Text] [Related]
22. [Prolymphocytic B-cell leukemia with fatal acute liver failure. A case report].
Steidl L; Rossi A; Cornaggia M; Crippa G; Venco A
Recenti Prog Med; 1994 Mar; 85(3):186-9. PubMed ID: 8184202
[TBL] [Abstract][Full Text] [Related]
23. Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
Veillon DM; Nordberg ML; Glass J; Sattar T; Cotelingam JD
Am J Clin Pathol; 2001 Nov; 116(5):781-2. PubMed ID: 11710698
[No Abstract] [Full Text] [Related]
24. [Cutaneous localization of T-cell prolymphocytic leukemia].
Thomas A; Dompmartin A; Troussard X; Moreau A; Manard C; Leroy D
Ann Dermatol Venereol; 1995; 122(8):526-9. PubMed ID: 8572493
[TBL] [Abstract][Full Text] [Related]
25. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
[TBL] [Abstract][Full Text] [Related]
26. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
Döhner H; Ho AD; Thaler J; Stryckmans P; Sonneveld P; de Witte T; Lechner K; Lauria F; Bödewadt-Radzun S; Suciu S
J Natl Cancer Inst; 1993 Apr; 85(8):658-62. PubMed ID: 8468724
[TBL] [Abstract][Full Text] [Related]
27. Seropositive polyarthritis and skin manifestations in T-prolymphocytic leukemia/Sezary cell leukemia variant.
Dybjer A; Hellquist L; Johansson B; Rydgren L; Billström R
Leuk Lymphoma; 2000 Apr; 37(3-4):437-40. PubMed ID: 10752996
[TBL] [Abstract][Full Text] [Related]
28. Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome.
Foucar K
Am J Clin Pathol; 2007 Apr; 127(4):496-510. PubMed ID: 17369126
[TBL] [Abstract][Full Text] [Related]
29. Small cell variant of T-cell prolymphocytic leukemia exhibiting suppressor phenotype.
Thorat KB; Gujral S; Kumar A; Nair CN
Leuk Lymphoma; 2006 Aug; 47(8):1711-3. PubMed ID: 16966296
[No Abstract] [Full Text] [Related]
30. Skin and gingival lesions in a young woman with B-prolymphocytic leukemia (B-PLL).
Panteli K; Bai M; Basioukas K; Vartholomatos G; Zioga K; Bourantas KL
J Exp Clin Cancer Res; 2001 Sep; 20(3):447-9. PubMed ID: 11718228
[TBL] [Abstract][Full Text] [Related]
31. Salvage chemotherapy with pentostatin in prolymphocytic leukemia.
Pagano L; Ortu-La Barbera EO; Voso MT; Zollino M; Laurenti L; Marra R; Leone G
Haematologica; 1994; 79(6):542-5. PubMed ID: 7896214
[TBL] [Abstract][Full Text] [Related]
32. Production of vascular endothelial growth factor in T-cell prolymphocytic leukemia.
Ogasawara T; Narita C; Kawauchi K
Leuk Res; 2007 Mar; 31(3):403-6. PubMed ID: 16620970
[TBL] [Abstract][Full Text] [Related]
33. Periorbital edema as the initial presentation of T-cell prolymphocytic leukemia.
Nusz KJ; Pang NK; Woog JJ
Ophthalmic Plast Reconstr Surg; 2006; 22(3):215-6. PubMed ID: 16714934
[TBL] [Abstract][Full Text] [Related]
34. T-cell prolymphocytic leukemia involving extramedullary sites.
Valbuena JR; Herling M; Admirand JH; Padula A; Jones D; Medeiros LJ
Am J Clin Pathol; 2005 Mar; 123(3):456-64. PubMed ID: 15716243
[TBL] [Abstract][Full Text] [Related]
35. Small cell variant type of T-prolymphocytic leukemia with a four-year indolent course preceding acute exacerbation.
Shimizu D; Nomura K; Matsumoto Y; Nishida K; Taki T; Horiike S; Inaba T; Fujita N; Taniwaki M
Leuk Lymphoma; 2006 Jun; 47(6):1170-2. PubMed ID: 16840216
[No Abstract] [Full Text] [Related]
36. Prolymphocytic leukaemia--report of three cases.
Nayak KS; Shankarnarayanan ; Naik R; Khadilkar UN
J Indian Med Assoc; 2004 Jul; 102(7):379-80. PubMed ID: 15717584
[TBL] [Abstract][Full Text] [Related]
37. Are activation markers (CD25, CD38 and CD103) predictive of sensitivity to purine analogues in patients with T-cell prolymphocytic leukemia and other lymphoproliferative disorders?
Delgado J; Bustos JG; Jimenez MC; Quevedo E; Hernandez-Navarro F
Leuk Lymphoma; 2002 Dec; 43(12):2331-4. PubMed ID: 12613520
[TBL] [Abstract][Full Text] [Related]
38. Prolymphocytic leukemia.
Absi A; Hsi E; Kalaycio M
Curr Treat Options Oncol; 2005 May; 6(3):197-208. PubMed ID: 15869731
[TBL] [Abstract][Full Text] [Related]
39. A brief intensive chemotherapy in T-prolymphocytic leukemia.
Billio A; Pescosta N; Rosanelli C; Fabris P; Coser P
Haematologica; 2000 Apr; 85(4):438-9. PubMed ID: 10756378
[No Abstract] [Full Text] [Related]
40. Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature.
Abbi KK; Rizvi SM; Sivik J; Thyagarajan S; Loughran T; Drabick JJ
Leuk Res; 2010 Jul; 34(7):e154-6. PubMed ID: 20362332
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
